Portage Biotech Inc.
PRTG
$5.42
-$0.54-9.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.25M | 4.68M | 5.02M | 5.83M | 5.67M |
| Depreciation & Amortization | 35.00K | 38.00K | 43.00K | 51.00K | 54.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.42M | 9.20M | 11.76M | 16.09M | 18.25M |
| Operating Income | -7.42M | -9.20M | -11.76M | -16.09M | -18.25M |
| Income Before Tax | -6.78M | -29.81M | -76.81M | -81.52M | -85.93M |
| Income Tax Expenses | -3.00K | 500.00 | -9.49M | -10.40M | -10.55M |
| Earnings from Continuing Operations | -6.78 | -29.82 | -67.32 | -71.12 | -75.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 11.00K | 34.50K | 39.00K | 44.00K | 43.00K |
| Net Income | -6.77M | -29.78M | -67.28M | -71.08M | -75.34M |
| EBIT | -7.42M | -9.20M | -11.76M | -16.09M | -18.25M |
| EBITDA | -7.38M | -9.16M | -11.72M | -16.04M | -18.20M |
| EPS Basic | -5.72 | -28.03 | -64.27 | -68.81 | -73.92 |
| Normalized Basic EPS | -3.57 | -1.33 | -4.37 | -7.76 | -10.27 |
| EPS Diluted | -5.72 | -28.03 | -64.28 | -68.81 | -73.92 |
| Normalized Diluted EPS | -3.57 | -1.33 | -4.37 | -7.76 | -10.27 |
| Average Basic Shares Outstanding | 4.73M | 4.48M | 4.22M | 4.03M | 3.87M |
| Average Diluted Shares Outstanding | 4.73M | 4.48M | 4.22M | 4.03M | 3.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |